A new approach that makes paper from straw, which cuts production costs and is kinder to the planet, is one step closer to reality thanks to an investment award of £90,500 from NESTA (the National Endowment for Science, Technology and the Arts) – the organisation that nurtures UK creativity and innovation.
The innovation is the brainchild of a Surrey-based environmental company, BioRegional MiniMills Ltd. The driving force behind this company is a former nurse, Sue Riddlestone who became very active in the environmental field after starting a family. Following a stint of voluntary work for the eco-lobby group Greenpeace, she co-founded BioRegional as an environmental charity. It works in partnership with industry to develop sustainable production and lifestyles through practical projects. The MiniMills offshoot was established in 1997 to develop new, cleaner technology to make paper on a small scale. Sue is joined by a range of experts from the paper processing industry.
There are reported to be nearly 9,000 paper and board mills worldwide, and the demand for paper is growing at a rate of 3% per annum. Current mills are huge operations run by multi-national companies. However, MiniMills’ new process would allow more independent paper makers to compete with these large-scale processes. Their method would facilitate the use of a much greater variety of raw materials, including straw - four million tonnes of straw goes unused in the UK annually - and wood from sustainably-managed, smaller woodlands for use in papermaking. This would provide income generation for both farmers and foresters.
Joseph Meaney | alfa
Clean without scrubbing and using chemicals
28.05.2020 | Technische Universität Dresden
Decontaminating pesticide-polluted water using engineered nanomaterial and sunlight
16.01.2020 | Institut national de la recherche scientifique - INRS
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering